• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛查时代乳腺癌研究中的偏倚

Bias in breast cancer research in the screening era.

作者信息

Cox Brian, Sneyd Mary J

机构信息

Hugh Adam Cancer Epidemiology Unit, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

出版信息

Breast. 2013 Dec;22(6):1041-5. doi: 10.1016/j.breast.2013.07.046. Epub 2013 Aug 26.

DOI:10.1016/j.breast.2013.07.046
PMID:23988397
Abstract

Screening aims to detect breast cancer at an earlier stage than would occur if symptoms developed. The characteristics of breast cancer that are detectable at screening depend on both the physical properties of the screening test and specific anatomical features of breast cancer. As a result, breast cancer detected by screening is a select subset of all breast cancer existing in the population. Therefore, biomedical, clinical and epidemiological research into breast cancer using populations with access to screening can result in major bias. The biases, with examples, are explained.

摘要

筛查旨在比出现症状时更早地检测出乳腺癌。在筛查中可检测到的乳腺癌特征既取决于筛查测试的物理特性,也取决于乳腺癌的特定解剖特征。因此,通过筛查检测出的乳腺癌是人群中所有现存乳腺癌的一个特定子集。所以,对能够进行筛查的人群开展的乳腺癌生物医学、临床和流行病学研究可能会导致重大偏差。文中将对这些偏差及其示例进行解释。

相似文献

1
Bias in breast cancer research in the screening era.筛查时代乳腺癌研究中的偏倚
Breast. 2013 Dec;22(6):1041-5. doi: 10.1016/j.breast.2013.07.046. Epub 2013 Aug 26.
2
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.考虑到提前期和长度偏倚,对筛查发现的和有症状的乳腺癌女性的生存情况进行人群估计。
Breast Cancer Res Treat. 2009 Jul;116(1):179-85. doi: 10.1007/s10549-008-0100-8. Epub 2008 Jul 12.
3
Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.荷兰病例对照研究中,自身选择偏倚对乳腺癌筛查效果的影响较小。
J Med Screen. 2011;18(3):142-6. doi: 10.1258/jms.2011.011027.
4
Cancer screening: the clash of science and intuition.癌症筛查:科学与直觉的冲突。
Annu Rev Med. 2009;60:125-37. doi: 10.1146/annurev.med.60.101107.134802.
5
Value of mammographic screening: assessment of studies and opinion.
Radiographics. 1990 Nov;10(6):1133-9. doi: 10.1148/radiographics.10.6.2259768.
6
New citizens' juries in breast screening review are biased.乳腺筛查审查中的新公民陪审团存在偏见。
BMJ. 2012 Nov 19;345:e7552. doi: 10.1136/bmj.e7552.
7
Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.基于人群的科多尔(法国)乳腺癌筛查研究:临床意义和影响筛查轮次充足性的因素。
Eur J Cancer Prev. 2011 Nov;20(6):462-74. doi: 10.1097/CEJ.0b013e328345f959.
8
Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival.在估计筛查检测对癌症生存的影响时校正领先时间和长度偏倚。
Am J Epidemiol. 2008 Jul 1;168(1):98-104. doi: 10.1093/aje/kwn120. Epub 2008 May 25.
9
Breast cancer screening.乳腺癌筛查
Prim Care. 1992 Sep;19(3):575-88.
10
Secondary prevention: screening for breast cancer.二级预防:乳腺癌筛查。
Eff Health Care. 1985;2(5):179-88.

引用本文的文献

1
Early detection of triple-negative breast cancer: evidence of a favourable prognostic impact in a comparative analysis of screen-detected versus symptomatic cases.三阴性乳腺癌的早期检测:在筛查发现病例与有症状病例的对比分析中具有良好预后影响的证据。
BMC Cancer. 2025 Apr 18;25(1):730. doi: 10.1186/s12885-025-14067-2.
2
Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts.基线筛查时诊断为轻度非肿瘤性病变的患者能否安全地免于监测:来自多中心社区队列的证据。
Sci China Life Sci. 2025 Jan;68(1):263-271. doi: 10.1007/s11427-023-2558-x. Epub 2024 Sep 6.
3
Identification of modules and key genes associated with breast cancer subtypes through network analysis.
通过网络分析鉴定与乳腺癌亚型相关的模块和关键基因。
Sci Rep. 2024 May 29;14(1):12350. doi: 10.1038/s41598-024-61908-4.
4
Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.参加瑞士乳腺 X 光筛查计划“donna”的乳腺癌患者的生存时间延长。
Breast Cancer Res. 2024 May 27;26(1):84. doi: 10.1186/s13058-024-01841-6.
5
German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.德国乳房 X 光筛查计划:参与情况、(非)参与者特征以及非筛查性乳房 X 光检查的利用情况——一项纵向分析。
BMC Public Health. 2023 Aug 31;23(1):1678. doi: 10.1186/s12889-023-16589-5.
6
Tumour Growth Models of Breast Cancer for Evaluating Early Detection-A Summary and a Simulation Study.用于评估早期检测的乳腺癌肿瘤生长模型——综述与模拟研究
Cancers (Basel). 2023 Jan 31;15(3):912. doi: 10.3390/cancers15030912.
7
Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma.用于高级别尿路上皮癌早期检测和干预研究的天然犬类模型的鉴定。
Front Oncol. 2022 Nov 11;12:1011969. doi: 10.3389/fonc.2022.1011969. eCollection 2022.
8
Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.乳腺 X 线筛查与更有利的乳腺癌肿瘤特征和更好的总体生存相关:3739 例亚洲乳腺癌患者的病例对照分析。
BMC Med. 2022 Aug 4;20(1):239. doi: 10.1186/s12916-022-02440-y.
9
Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.基于患者就诊表现的安大略省乳腺癌诊断差异:一项回顾性队列研究。
CMAJ Open. 2022 Apr 5;10(2):E313-E330. doi: 10.9778/cmajo.20210254. Print 2022 Apr-Jun.
10
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis.通过乳房X线筛查发现的三阴性和HER2阳性乳腺癌显示出极佳的预后。
Breast Cancer Res Treat. 2021 May;187(1):267-274. doi: 10.1007/s10549-020-06060-z. Epub 2021 Jan 8.